Human papillomavirus vaccine - Berna BiotechAlternative Names: HPV vaccine - Berna Biotech
Latest Information Update: 16 Jun 2011
At a glance
- Originator Berna Biotech
- Developer Crucell
- Class Cancer vaccines; Papillomavirus vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Human papillomavirus infections
Most Recent Events
- 30 Dec 2002 Preclinical trials in Human papillomavirus infections in Switzerland (Intranasal)